Lido Advisors, LLC

Position in HROW — Harrow, Inc.

CIK 1650150 Los Angeles, CA

Position in HROW

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$580,732

-$374,082 QoQ

Shares Held

16,470

-15.5% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Lido Advisors, LLC holds $13,162,070 across 14 Drug Manufacturers - Specialty & Generic names. HROW ranks #7 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	56,855	$4,312,451
2	ZTS	Zoetis Inc.	17,207	$2,034,038
3	BHC	Bausch Health Companies Inc.	371,629	$2,006,796
4	UTHR	UNITED THERAPEUTICS Corp	1,653	$980,195
5	TEVA	Teva Pharmaceutical Industries Ltd	20,197	$608,333
6	HLN	Haleon plc	59,908	$599,679
7	HROW	Harrow, Inc. This page	16,470	$580,732
8	TAK	Takeda Pharmaceutical Co Ltd	22,886	$423,848

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$580,732	16,470	-15.5%	Shares	Sole	2026-05-13
2025-12-31	$954,814	19,486	0.0%	Shares	Sole	2026-02-10
2025-09-30	$938,835	19,486	+0.1%	Shares	Sole	2025-11-14
2025-06-30	$594,613	19,470	0.0%	Shares	Sole	2025-08-13
2025-03-31	$517,902	19,470	+74.8%	Shares	Sole	2025-05-15
2024-12-31	$373,747	11,140	-1.7%	Shares	Sole	2025-02-14
2024-09-30	$509,756	11,338	+8.0%	Shares	Sole	2024-11-14
2024-06-30	$219,345	10,500	0.0%	Shares	Sole	2024-08-15
2024-03-31	$138,915	10,500	0.0%	Shares	Sole	2024-05-15
2023-12-31	$117,600	10,500	0.0%	Shares	Sole	2024-02-14
2023-09-30	$150,885	10,500	0.0%	Shares	Sole	2023-11-14
2023-06-30	$199,920	10,500	0.0%	Shares	Sole	2023-08-09
2023-03-31	$222,180	10,500	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.